Press release
What's Driving the Omeprazole Market 2025-2034: Impact Of Rising Gastric Cancer Incidence On The Growth Of The Omeprazole Market
Omeprazole Analysis
The market size for omeprazole has seen significant expansion in the past years. Its value is expected to increase from $2.34 billion in 2024 to $2.52 billion in 2025 with a compound annual growth rate (CAGR) of 7.9%. The surge in growth during the historic period can be traced back to factors such as recompense regulations, a shift from H2 blockers to proton pump inhibitors by patients and healthcare providers, educational programs promoting the advantages of omeprazole treatment, government expenditure on healthcare facilities and services, and initiatives to enhance health literacy.
In the coming years, the omeprazole market size is projected to experience robust growth. A compound annual growth rate (CAGR) of 7.6% will cause it to soar to $3.39 billion by 2029. Government initiatives to regulate drug prices that impact profitability, disturbances in the pharmaceutical supply chain meddling with omeprazole availability and cost, customized treatment strategies, rise in consumer knowledge and inclination towards self-care products, and alterations in disease patterns and prevalence rates dictating the demand for omeprazole are various factors that contribute to the growth in the forecasted period. The forecast period is also characterized by significant trends such as the development of gene editing technologies, advancements in pharmacogenomics, the adoption of telemedicine, the integration of digital health technologies, and the expansion of online platforms.
What Are the Primary Growth Drivers for the Omeprazole Market?
The surge in the prevalence of stomach cancers is anticipated to bolster the expansion of the omeprazole market. Gastric cancers, referring to tumors Starting in the stomach lining, have seen an uptick due to factors such as chronic helicobacter pylori infection, excessive alcohol use, genetic factors, ongoing gastritis, obesity, and variations in geographical prevalence. Omeprazole, a type of proton pump inhibitor, plays an important role in managing stomach cancers by suppressing acid production in the stomach, thereby easing symptoms, enhancing life quality, and promoting the healing of ulcers or lesions in the stomach lining. To illustrate, in January 2023, data from the American Cancer Society (ACS), a health organization based in the U.S. committed to the eradication of cancer, showed a 3.18% increase in gastrointestinal cancers, with cases rising to 348,840 from the prior year's 338,090 in the U.S. Therefore, the rise in stomach cancer cases is fueling the growth of the omeprazole market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16495&type=smp
Which Businesses Are at the Forefront of Omeprazole Market Development?
Major companies operating in the omeprazole market are Pfizer Inc., AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Fresenius Kabi, Macleods Pharmaceuticals Pvt Ltd., Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals, Jubilant Generics Limited, Accord Healthcare, Hetero Healthcare Limited, Zydus Cadila, Ranbaxy Laboratories Limited
What Are the Latest Innovations in the Omeprazole Market?
Top enterprises in the omeprazole industry are creating ready-to-use liquid versions to boost the ease of use and adherence of patients, particularly those struggling with swallowing pills or capsules. Such formulations of omeprazole increase patient adherence, simplify usage, offer precise dosages, allow for quicker action, and ensure superior drug stability. For instance, in February 2024, North Macedonia's pharmaceutical producer, Alkaloid AD, introduced liquid Omeprazole as the first readily-available liquid format specifically for reflux esophagitis and GERD patients incapable of swallowing tablets. The product comes in a dual-chamber packaging, making it a more feasible and reachable treatment alternative for individuals having issues with swallowing pills or capsules, like young kids, adults with dysphagia, and those with gastric feeding tubes or elderly patients. The company secured the first international patent for this value-added medicine (VAM) and has received approval to market this product in the Macedonian and UK markets.
How Is the Omeprazole Market Segmented?
The omeprazole market covered in this report is segmented -
1) By Dosage Form: Capsule, Powder, Tablet
2) By Indication: Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Erosive Esophagitis, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Capsule: Delayed-Release Capsules, Immediate-Release Capsules
2) By Powder: Oral Suspension Powder, Injectable Powder
3) By Tablet: Delayed-Release Tablets, Immediate-Release Tablets
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/omeprazole-global-market-report
Where Is the Omeprazole Market Growth Most Prominent?
North America was the largest region in the omeprazole market in 2024. The regions covered in the omeprazole market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Omeprazole Global Market Report?
- Market Size Analysis: Analyze the Omeprazole Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Omeprazole Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Omeprazole Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Omeprazole Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16495
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's Driving the Omeprazole Market 2025-2034: Impact Of Rising Gastric Cancer Incidence On The Growth Of The Omeprazole Market here
News-ID: 3864640 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Omeprazole
Evolving Market Trends In The Omeprazole Industry: Advancements In Omeprazole Fo …
The Omeprazole Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Omeprazole Market Size During the Forecast Period?
The omeprazole market has seen considerable growth in recent years. It is projected to rise from $2.34 billion in 2024 to $2.52 billion in 2025,…
Prominent Omeprazole Market Trend for 2025: Advancements In Omeprazole Formulati …
What combination of drivers is leading to accelerated growth in the omeprazole market?
The rising incidence of gastric cancers is expected to contribute to the growth of the omeprazole market. Gastric cancers are typically linked to factors like Helicobacter pylori infection and lifestyle habits. Omeprazole, a medication that reduces stomach acid production, helps alleviate symptoms and promote healing. In January 2023, the American Cancer Society reported a 3.18% increase in gastrointestinal…
Omeprazole Market Size, Share, Growth, Trends And Forecast 2024-2033
The new report published by The Business Research Company, titled Omeprazole Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the omeprazole market size has grown strongly in recent years. It will grow from $2.17 billion in 2023 to $2.34…
Omeprazole Market Size, Share, Growth, Trends, Analysis and Forecast - 2028
The global omeprazole market is anticipated to grow at a CAGR of 5.1% during the forecast period (2022-2028).
Omeprazole, is a proton pump inhibitor (PPI) that reduces the amount of acid produced in the stomach. Omeprazole is a medicine that can be used alone or in conjunction with other medications. It is used to treat GERD, ulcers, and other disorders brought on by too much stomach acid. The market is…
Omeprazole Market - Increasing prevalence of peptic ulcers is expected to propel …
The report presents an in-depth assessment of the Omeprazole Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the…
Proton Pump Inhibitors (PPIs) Market 2017 - Pantoprazole, Omeprazole, Lansoprazo …
Worldwide Proton Pump Inhibitors (PPIs) Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Proton Pump Inhibitors (PPIs) piece of the overall industry and Growth patterns, concentrating on driving Proton Pump Inhibitors (PPIs) industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022.
Get Free Sample Copy of Report Here: https://goo.gl/ydpu7k
Top Manufacturers Analysis of This Report
AstraZeneca,
Pfizer,
Janssen,
Eisai,
Eli Lilly,
Cadila Pharmaceuticals,
Santarus,…
